

Vivitra 150 mg Injection is a prescription medicine used for HER2-positive breast and gastric cancers. It contains Trastuzumab 150 mg, a monoclonal antibody that blocks HER2 protein activity, helping to slow or stop cancer cell growth. This injection is administered via IV infusion under medical supervision. Vivitra 150 mg Injection is suitable for patients at different cancer stages, either as a standalone treatment or combined with chemotherapy. Its targeted action offers a safer, more precise cancer therapy with fewer side effects compared to conventional chemotherapy methods.
| SKU | CMS3090 |
| USA Brand Name | Vivitra |
| Strength | 150mg |
| Generic Name | Trastuzumab |
| Manufacturer | Zydus Cadila |
| Variant | Price | Units | Quantity | Add to Cart |
|---|---|---|---|---|
| 2 Injection | $739.80 | $369.90 | ||
| 4 Injection | $1,440.99 | $360.25 | ||
| 6 Injection | $2,122.89 | $353.82 |
| size | 2 Injection, 4 Injection, 6 Injection |
|---|
Reviews
There are no reviews yet.